Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2016 2
2017 2
2018 2
2019 3
2020 2
2021 5
2022 8
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
1,6-Naphthyridin-2(1H)-ones: Synthesis and Biomedical Applications.
Oliveras JM, Puig de la Bellacasa R, Estrada-Tejedor R, Teixidó J, Borrell JI. Oliveras JM, et al. Among authors: estrada tejedor r. Pharmaceuticals (Basel). 2021 Oct 9;14(10):1029. doi: 10.3390/ph14101029. Pharmaceuticals (Basel). 2021. PMID: 34681253 Free PMC article. Review.
1H-Pyrazolo[3,4-b]pyridines: Synthesis and Biomedical Applications.
Donaire-Arias A, Montagut AM, Puig de la Bellacasa R, Estrada-Tejedor R, Teixidó J, Borrell JI. Donaire-Arias A, et al. Among authors: estrada tejedor r. Molecules. 2022 Mar 30;27(7):2237. doi: 10.3390/molecules27072237. Molecules. 2022. PMID: 35408636 Free PMC article. Review.
Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.
Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S. Bou-Petit E, et al. Among authors: estrada tejedor r. J Med Chem. 2022 Apr 28;65(8):6070-6087. doi: 10.1021/acs.jmedchem.1c01941. Epub 2022 Apr 13. J Med Chem. 2022. PMID: 35417652 Free PMC article.
ALK and ROS1 as a joint target for the treatment of lung cancer: a review.
Puig de la Bellacasa R, Karachaliou N, Estrada-Tejedor R, Teixidó J, Costa C, Borrell JI. Puig de la Bellacasa R, et al. Among authors: estrada tejedor r. Transl Lung Cancer Res. 2013 Apr;2(2):72-86. doi: 10.3978/j.issn.2218-6751.2013.03.1. Transl Lung Cancer Res. 2013. PMID: 25806218 Free PMC article. Review.
29 results